Ferrlecit 12.5 mg/mL

Ferrlecit 12.5 mg/mL is an intravenous injection containing sodium ferric gluconate complex. It is used to treat iron deficiency anemia in patients undergoing dialysis. This medication helps replenish iron stores in the body.

Ferrlecit 12.5 mg/mL is primarily used to address iron deficiency anemia, particularly in patients undergoing dialysis. It provides a direct source of iron to help the body produce red blood cells. This medication is administered intravenously to ensure effective absorption and utilization of iron.

Common effects of Ferrlecit 12.5 mg/mL may include temporary discomfort at the injection site, such as redness or swelling. Some patients may experience flu-like symptoms, including fever, chills, or muscle aches. These effects are generally mild and short-lived.

Ferrlecit 12.5 mg/mL should be administered under medical supervision to monitor for any adverse reactions. Patients with a history of allergic reactions to iron preparations should use this medication with caution. It is important to follow the prescribed dosage and administration guidelines to minimize potential risks.

Ferrlecit 12.5 mg/mL may interact with other medications, particularly those that affect iron metabolism. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.